Cystic Fibrosis. Cystic fibrosis with pulmonary manifestations
Conditions
Interventions
Intervention 1: Intervention group:Before starting the intervention, the dependent variable is based on the routine of the lung clinic before the intervention, in the lung clinic with a model spiromet
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
8 Years to 18 Years
Inclusion criteria
Inclusion criteria: The participant must have a positive sweat test (chloride value = 60 mmol/L) (11). Patients with a positive sweat test should go to the lung clinic of the Children's Medical Center. Children should be between the ages of 8-18 years. The child should not have a history of working with an oral instrument. Patients who have been referred for the first time and have recently been diagnosed with a disease and do not have a history of performing airway cleaning routine, will not be included in the study.
Exclusion criteria
Exclusion criteria: Patients who have a history of playing wind instruments. Patients who present for the first time and have a newly diagnosed disease and do not perform routine airway clearance.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Forced exhalation reserve volume in the first second, scientific definition: the amount of air that is forced out of the lungs with pressure in the first second (27). Practical definition: it is a respiratory parameter that is measured in the spirometry test. Timepoint: Before the start of the intervention, two months after the start of the intervention. Method of measurement: In this study, respiratory factors are measured with a spirometry device made in Austria, Schiller factory, GANSHORN SpiroScout model and a spirometry filter made by Lemon Medical Company. The device is periodically calibrated according to the protocol of the Children's Medical Center hospital. | — |
Secondary
| Measure | Time frame |
|---|---|
| Forced vital capacity, scientific definition. : The volume of air that comes out of the lungs with maximum power after a deep breath (27). Practical definition: It is a respiratory parameter that is measured in the spirometry test. Timepoint: Before the start of the intervention, two months after the start of the intervention. Method of measurement: In this study, respiratory factors are measured with a spirometry device made in Austria, Schiller factory, GANSHORN SpiroScout model and a spirometry filter made by Lemon Medical Company. The device is periodically calibrated according to the protocol of the Children's Medical Center hospital. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHanieh Tavassoli
Tehran University of Medical Sciences
Outcome results
None listed